Body size measurement |  | ER+ tumors |  |  | ER– tumors |  |
---|---|---|---|---|---|---|
p-mTOR overexpressed cases vs controls | p-mTOR negative/low cases vs controls | P-heterogeneity | p-mTOR overexpressed cases vs controls | p-mTOR negative/low cases vs controls | P-heterogeneity | |
OR (95% CI) | OR (95% CI) | Â | OR (95% CI) | OR (95% CI) | Â | |
BMI, kg/m2 | ||||||
 No. of cases/no. of controls | 164/1973 | 309/1973 |  | 25/1973 | 211/1973 |  |
  < 25 | 1.00 [reference] | 1.00 [reference] |  | 1.00 [reference] | 1.00 [reference] |  |
 25–29.99 | 1.29 (0.77–2.16) | 1.02 (0.72–1.45) |  | 0.83 (0.23–2.99) | 1.00 (0.68–1.49) |  |
 30–34.99 | 1.48 (0.87–2.52) | 1.33 (0.92–1.91) |  | 1.72 (0.54–5.48) | 0.84 (0.54–1.31) |  |
  ≥ 35 | 1.39 (0.82–2.34) | 0.75 (0.51–1.11) | 0.015 | 0.90 (0.25–3.25) | 0.61 (0.39–0.96) | 0.09 |
P-trend | 0.27 | 0.18 | Â | 0.97 | 0.015 | Â |
WC | ||||||
 No. of cases/no. of controls | 162/1955 | 304/1955 |  | 25/1955 | 206/1955 |  |
 Q1 | 1.00 [reference] | 1.00 [reference] |  | 1.00 [reference] | 1.00 [reference] |  |
 Q2 | 1.65 (0.90–3.01) | 1.09 (0.74–1.60) |  | 1.81 (0.32–10.1) | 1.09 (0.70–1.70) |  |
 Q3 | 2.28 (1.28–4.06) | 1.36 (0.93–1.98) |  | 4.70 (1.00–22.07) | 1.04 (0.57–1.63) |  |
 Q4 | 1.93 (1.06–3.51) | 1.01 (0.67–1.50) | 0.26 | 2.60 (0.50–13.6) | 0.83 (0.52–1.32) | 0.55 |
P-trend | 0.050 | 0.97 | Â | 0.25 | 0.31 | Â |
WHR | ||||||
 No. of cases/no. of controls | 162/1955 | 304/1955 |  | 25/1955 | 206/1955 |  |
 Q1 | 1.00 [reference] | 1.00 [reference] |  | 1.00 [reference] | 1.00 [reference] |  |
 Q2 | 1.17 (0.57–2.04) | 1.34 (0.91–1.98) |  | 1.58 (0.26–9.59) | 1.34 (0.85–2.10) |  |
 Q3 | 1.54 (0.91–2.60) | 1.47 (1.00–2.15) |  | 5.35 (1.16–24.71) | 1.28 (0.80–2.03) |  |
 Q4 | 1.69 (1.01–2.84) | 1.37 (0.93–2.03) | 0.36 | 3.42 (0.68–17.16) | 1.60 (0.99–2.58) | 0.89 |
P-trend | 0.027 | 0.14 | Â | 0.08 | 0.38 | Â |